Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference

Integra LifeSciences (NASDAQ: IART), a leading global medical technology company, has announced its participation in the 22nd Annual Morgan Stanley Healthcare Conference.

Rhea-AI Summary

Integra LifeSciences (NASDAQ: IART), a leading global medical technology company, has announced its participation in the 22nd Annual Morgan Stanley Healthcare Conference. Lea Knight, the company's chief financial officer, is scheduled to present on September 6, 2024, at 10:45am ET.

The presentation will be accessible via a live webcast on Integra LifeSciences' investor relations website. This event provides an opportunity for investors and analysts to gain insights into the company's recent developments, financial performance, and future outlook within the healthcare technology sector.

Integra LifeSciences' participation in this prestigious conference underscores its commitment to engaging with the investment community and showcasing its position in the medical technology market.

Argus Publication session

-0.72% session move Open Argus

Details

News Market Reaction – IART

In the trading session that priced this news, IART declined 0.72%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the Morgan Stanley Healthcare conference on September 6, 2024 at 10:45am ET.

A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at https://investor.integralife.com/events-and-presentations.

About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit investor.integralife.com.  

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com   

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com 

Integra LifeSciences Holdings Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Integra LifeSciences (IART) presenting at the Morgan Stanley Healthcare Conference?

Integra LifeSciences (IART) is presenting at the Morgan Stanley Healthcare Conference on September 6, 2024, at 10:45am ET.

Who will be representing Integra LifeSciences (IART) at the Morgan Stanley Healthcare Conference?

Lea Knight, the chief financial officer of Integra LifeSciences (IART), will be presenting at the Morgan Stanley Healthcare Conference.

How can investors watch Integra LifeSciences' (IART) presentation at the Morgan Stanley Healthcare Conference?

Investors can watch a live webcast of Integra LifeSciences' (IART) presentation on the company's investor relations website at https://investor.integralife.com/events-and-presentations.

What is the significance of Integra LifeSciences (IART) participating in the Morgan Stanley Healthcare Conference?

Integra LifeSciences' (IART) participation in the Morgan Stanley Healthcare Conference provides an opportunity for the company to showcase its position in the medical technology market and engage with the investment community.